vimarsana.com

Latest Breaking News On - Therapeutics company profile - Page 36 : vimarsana.com

Knights of Columbus Asset Advisors LLC Boosts Stock Position in Viking Therapeutics, Inc (NASDAQ:VKTX)

Knights of Columbus Asset Advisors LLC raised its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 3.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,557 shares of the biotechnology company’s stock after purchasing an additional 1,226 shares […]

Short Interest in CRISPR Therapeutics AG (NASDAQ:CRSP) Declines By 6 2%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 16,250,000 shares, a drop of 6.2% from the December 15th total of 17,330,000 shares. Based on an average daily trading volume, of 2,750,000 shares, the short-interest ratio is presently […]

Analysts Set CRISPR Therapeutics AG (NASDAQ:CRSP) Price Target at $68 39

Analysts Set CRISPR Therapeutics AG (NASDAQ:CRSP) Price Target at $68 39
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

PHAXIAM Therapeutics (NASDAQ:PHXM) Shares Down 9 4%

PHAXIAM Therapeutics (NASDAQ:PHXM) Shares Down 9 4%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.